The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus

European Urology

Volumn 59, Issue 6, 2011, Pages 912-918

  Cost, Nicholas G ^a   Delacroix Jr , Scott E ^b   Sleeper, Joshua P ^a   Smith, Paul J ^a   Youssef, Ramy F ^a   Chapin, Brian F ^b   Karam, Jose A ^b   Culp, Stephen ^b   Abel, E Jason ^b   Brugarolas, James ^a   Raj, Ganesh V ^a   Sagalowsky, Arthur I ^a   Wood, Christopher G ^b   Margulis, Vitaly ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Renal cell carcinoma; Targeted molecular therapies; Tumor thrombus

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; SUNITINIB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DATA BASE; DISEASE CLASSIFICATION; FEMALE; HUMAN; INFERIOR VENA CAVA TUMOR THROMBUS; KIDNEY CARCINOMA; KIDNEY VEIN; MALE; MEDICAL RECORD REVIEW; NEPHRECTOMY; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL APPROACH; THROMBOCYTE COUNT; TREATMENT DURATION; TUMOR REGRESSION; TUMOR THROMBUS; TUMOR VOLUME;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; PROTEIN KINASE INHIBITORS; PYRROLES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TEXAS; THROMBECTOMY; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 79955624714     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.02.032     Document Type: Article

References (25)

1. R.J. Karnes, and M.L. Blute Surgery insight: management of renal cell carcinoma with associated inferior vena cava thrombus Nat Clin Pract Urol 5 2008 329 339 (Pubitemid 351818885)
2. E.H. Lambert, P.M. Pierorazio, A. Shabsigh, C.A. Olsson, M.C. Benson, and J.M. McKiernan Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus Urology 69 2007 1054 1058 (Pubitemid 46891594)
3. T. Klatte, A.J. Pantuck, and S.B. Riggs Prognostic factors for renal cell carcinoma with tumor thrombus extension J Urol 178 2007 1189 1195 discussion 1195 (Pubitemid 47368397)
4. F. Di Silverio, A. Sciarra, and U. Parente Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy Urol Int 80 2008 451 453 (Pubitemid 351915038)
5. B. Shuch, S.B. Riggs, and J.C. LaRochelle Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm BJU Int 102 2008 692 696
6. P.I. Karakiewicz, N. Suardi, and C. Jeldres Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi Eur Urol 53 2008 845 848 (Pubitemid 351273883)
7. T. Kondo, Y. Hashimoto, and H. Kobayashi Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects Jpn J Clin Oncol 40 2010 1173 1179
8. L.C. Harshman, S. Srinivas, A. Kamaya, and B.I. Chung Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib Nat Rev Urol 6 2009 338 343
9. G. Robert, G. Gabbay, and R. Bram Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma Eur Urol 55 2009 1477 1480
10. A. Bex, A.A. Van der Veldt, C. Blank, M.R. Meijerink, E. Boven, and J.B. Haanen Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib Acta Oncol 49 2010 520 523
11. J.R. Srigley, R.V. Hutter, and A.B. Gelb Current prognostic factors - renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 80 1997 994 996
12. A.B. Gelb Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 80 1997 981 986
13. F. Greene, D. Page, and I. Fleming AJCC cancer staging manual ed. 6 2002 Springer-Verlag New York, NY
14. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer, version 1.2011. National Comprehensive Cancer Network Web site. http://www.nccn.org.
15. Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS. Contemporary management of renal tumors with venous tumor thrombus. J Urol;184:833-41; quiz 1235.
16. D.J. Parekh, M.S. Cookson, and W. Chapman Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes J Urol 173 2005 1897 1902 (Pubitemid 40675206)
17. A.A. Thomas, B.I. Rini, and B.R. Lane Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma J Urol 181 2009 518 523 discussion 523
18. A.A. van der Veldt, M.R. Meijerink, and A.J. van den Eertwegh Sunitinib for treatment of advanced renal cell cancer: primary tumor response Clin Cancer Res 14 2008 2431 2436 (Pubitemid 351551077)
19. C. Amin, E. Wallen, R.S. Pruthi, B.F. Calvo, P.A. Godley, and W.K. Rathmell Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy Urology 72 2008 864 868
20. V. Margulis, and C.G. Wood Pre-surgical targeted molecular therapy in renal cell carcinoma BJU Int 103 2009 150 153
21. C.G. Wood, and V. Margulis Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease Cancer 115 2009 2355 2360
22. J.L. Silberstein, F. Millard, and R. Mehrazin Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery BJU Int 106 2010 1270 1276
23. N.J. Hellenthal, W. Underwood, and R. Penetrante Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma J Urol 184 2010 859 864
24. M. Schmidinger, D. Arnold, C. Szczylik, J. Wagstaff, and A. Ravaud Optimizing the use of sunitinib in metastatic renal cell carcinoma: an update from clinical practice Cancer Invest 28 2010 856 864
25. E.J. Abel, S.H. Culp, and N.M. Tannir Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma Eur Urol 59 2011 10 15